共 10 条
[1]
[2]
[3]
Dapagliflozin attenuates early markers of diabetic nephropathy in fructose-streptozotocin-induced diabetes in rats.[J].Mamdouh A. Oraby;Mohammed F. El-Yamany;Marwa M. Safar;Naglaa Assaf;Hamdy A. Ghoneim.Biomedicine & Pharmacotherapy.2019,
[6]
Dapagliflozin slows the progression of the renal and liver fibrosis associated with type 2 diabetes
[J].
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM,
2017, 313 (05)
:E563-E576
[7]
A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling.[J].Leonardo Schirone;Maurizio Forte;Silvia Palmerio;Derek Yee;Cristina Nocella;Francesco Angelini;Francesca Pagano;Sonia Schiavon;Antonella Bordin;Albino Carrizzo;Carmine Vecchione;Valentina Valenti;Isotta Chimenti;Elena De Falco;Sebastiano Sciarretta;Giacomo Frati;Stefano Toldo.Oxidative Medicine and Cellular Longevity.2017,
[8]

